Literature DB >> 23001327

Early histologic lesions and risk factors for recurrence of diabetic kidney disease after kidney transplantation.

Izumi Nyumura1, Kazuho Honda, Kazunari Tanabe, Satoshi Teraoka, Yasuhiko Iwamoto.   

Abstract

BACKGROUND: Recurrence of diabetic kidney disease (DKD) after diabetic kidney transplantation has been reported. The aim of this study was to determine the early histologic lesions, focusing especially on abnormal glomerular angiogenesis, and clinical risk factors of recurrent DKD after kidney transplantation.
METHODS: The authors studied 34 renal transplant recipients with diabetes and 30 without diabetes. All patients had undergone both baseline and posttransplant follow-up biopsies. Glomerular morphometric analyses of the mesangial area, the capillary number, and the capillary area were performed with a computer-assisted image analyzer, and glomerular basement membrane (GBM) thickness was evaluated by electron microscopy. The incidence of polar vasculosis as an angiogenic phenomenon was also evaluated. Clinical data including hemoglobin (Hb)A1c, blood pressure, urinary albumin excretion, and serum lipid profiles were compared with histologic parameters.
RESULTS: Together with the increased glomerular mesangial area and GBM thickness, the glomerular capillary number and area and the incidence of polar vasculosis were significantly higher in patients with diabetes. Most of these alterations were significantly associated with the mean posttransplant HbA1c levels but not with blood pressure or lipid profiles. In the multiple regression analysis, HbA1c level remained significantly associated with these histologic parameters.
CONCLUSIONS: Similar to mesangial expansion and GBM thickening, glomerular neovascularization represented by increased capillary number and area and glomerular polar vasculosis can occur as an early diabetic lesion in recurrent DKD. Posttransplant hyperglycemia is a significant risk factor predictive of the progression of recurrent DKD in kidney allografts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001327     DOI: 10.1097/TP.0b013e31825e4a5f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.

Authors:  Kengo Furuichi; Miho Shimizu; Yukio Yuzawa; Akinori Hara; Tadashi Toyama; Hiroshi Kitamura; Yoshiki Suzuki; Hiroshi Sato; Noriko Uesugi; Yoshifumi Ubara; Junichi Hohino; Satoshi Hisano; Yoshihiko Ueda; Shinichi Nishi; Hitoshi Yokoyama; Tomoya Nishino; Kentaro Kohagura; Daisuke Ogawa; Koki Mise; Yugo Shibagaki; Hirofumi Makino; Seiichi Matsuo; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2017-10-27       Impact factor: 2.801

Review 2.  Trajectories of kidney function in diabetes: a clinicopathological update.

Authors:  Megumi Oshima; Miho Shimizu; Masayuki Yamanouchi; Tadashi Toyama; Akinori Hara; Kengo Furuichi; Takashi Wada
Journal:  Nat Rev Nephrol       Date:  2021-08-06       Impact factor: 28.314

Review 3.  Diabetic nephropathy: Is it time yet for routine kidney biopsy?

Authors:  Maria L Gonzalez Suarez; David B Thomas; Laura Barisoni; Alessia Fornoni
Journal:  World J Diabetes       Date:  2013-12-15

4.  A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.

Authors:  Junichi Hoshino; Kengo Furuichi; Masayuki Yamanouchi; Koki Mise; Akinari Sekine; Masahiro Kawada; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Noriko Hayami; Tatsuya Suwabe; Naoki Sawa; Shigeko Hara; Takeshi Fujii; Kenichi Ohashi; Kiyoki Kitagawa; Tadashi Toyama; Miho Shimizu; Kenmei Takaichi; Yoshifumi Ubara; Takashi Wada
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

5.  Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.

Authors:  Kengo Furuichi; Miho Shimizu; Masayuki Yamanouchi; Junichi Hoshino; Norihiko Sakai; Yasunori Iwata; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Yukio Yuzawa; Hiroshi Kitamura; Yoshiki Suzuki; Hiroshi Sato; Noriko Uesugi; Yoshihiko Ueda; Shinichi Nishi; Tomoya Nishino; Kenichi Samejima; Kentaro Kohagura; Yugo Shibagaki; Hirofumi Makino; Seiichi Matsuo; Yoshifumi Ubara; Hitoshi Yokoyama; Takashi Wada
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.